XT
UTHR icon

XTX Topco’s United Therapeutics UTHR Stock Holding History

XTX Topco’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07M Buy
+13,055
New +$7.35M 0.09% 229
2026
Q1 		– Sell
-1,584
Closed -$772K – 4425
2025
Q4 		$772K Sell
1,584
-6,937
-81% -$3.23M 0.02% 1227
2025
Q3 		$3.57M Buy
8,521
+3,670
+76% +$1.23M 0.19% 75
2025
Q2 		$1.39M Buy
4,851
+3,835
+377% +$1.15M 0.06% 489
2025
Q1 		$313K Buy
+1,016
New +$348K 0.02% 1372
2024
Q3 		– Sell
-4,012
Closed -$1.28M – 2641
2024
Q2 		$1.28M Buy
+4,012
New +$1.06M 0.11% 274
2023
Q4 		– Sell
-5,311
Closed -$1.2M – 2182
2023
Q3 		$1.2M Buy
5,311
+3,108
+141% +$716K 0.2% 60
2023
Q2 		$486K Buy
+2,203
New +$488K 0.09% 386
2022
Q4 		– Sell
-1,081
Closed -$226K – 1532
2022
Q3 		$226K Buy
+1,081
New +$242K 0.06% 709

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

XTX Topco's UTHR Position: Q2 2026 in Review

XTX Topco opened a new position in United Therapeutics (UTHR) in Q2 2026: 13,055 shares worth $7.07M. The stake represents 0.09% of the portfolio and ranks #229 among its holdings. This is a return to the name: XTX Topco previously reported a position in UTHR as recently as Q4 2025.

XTX Topco first reported a position in UTHR in Q3 2022 and has held it in 9 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • XTX Topco held 13,055 shares of United Therapeutics worth $7.07M as of Q2 2026.
  • United Therapeutics was a new XTX Topco position in Q2 2026.
  • United Therapeutics made up 0.09% of XTX Topco's portfolio in Q2 2026, its #229 holding.
  • XTX Topco first reported a position in United Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.